A Study of Prevalence of EGFR Mutations in Participants With NSCLC

Roche

Status: Completed

Conditions: Non-Small Cell Lung Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT02695849

ML25269

Details and patient eligibility

About

This is a non-interventional, local, multicenter, cross-sectional study to determine the prevalence of epidermal growth factor receptor (EGFR) mutations in participants diagnosed with non-squamous non-small cell lung cancer (NSCLC).

Enrollment: 69 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Informed consent form signature
• Jordanian male and female participants greater than or equal to (>=) 18 years of age
• Histologically confirmed NSCLC
• Not participating in a study that involves an investigational agent within 30 days prior to enrollment

Exclusion criteria

• Other primary malignancy
• Fine needle aspiration samples

Trial design

69 participants in 1 patient group

NSCLC Participants

Description:

Participants with non-squamous NSCLC will be enrolled in this study.